Show Summary Details
Page of

Urinary incontinence and female urology 

Urinary incontinence and female urology
Urinary incontinence and female urology

John Reynard

, Simon F Brewster

, Suzanne Biers

, and Naomi Laura Neal

Page of

PRINTED FROM OXFORD MEDICINE ONLINE ( © Oxford University Press, 2021. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 27 February 2021

All aspects of female and male urinary incontinence assessment, investigation, and management are outlined. Definitions of incontinence are provided, with a review of the epidemiology, risk factors, and management of stress urinary incontinence (SUI), post-prostatectomy (male) incontinence, overactive bladder syndrome (OAB), mixed urinary incontinence, and incontinence in older populations. Conservative, drug, and surgical therapies are explored, including bulking agents, synthetic mid-urethral tapes, colposuspension, autologous fascial slings, and artificial urinary sphincters (AUS) for female SUI, and urethral slings and AUS for male incontinence, and botulinum toxin, ileocystoplasty, and sacral nerve stimulation for OAB. Clear management pathways are included which are supported by the International Continence Society, with guideline recommendations from the National Institute for Health and Care Excellence and European Association of Urology. Vesicovaginal fistula, urethral diverticulum, and pelvic organ prolapse (POP), are illustrated, and controversies including the use of mesh in POP and incontinence surgery, and anticholinergic drug burden in OAB are discussed.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.